The progress in corneal translational medicine.

Area of Science:

• Biomedical Engineering
• Ophthalmology
• Regenerative Medicine

Background:

• Global demand for cornea tissue outstrips supply from donation centers.
• Current alternatives like human amniotic membrane (HAM) face storage and immune rejection challenges.
• Corneal translational medicine seeks sustainable solutions for tissue replacement.

Purpose of the Study:

• To review recent advancements in cornea tissue engineering.
• To explore applications in biomaterial selection, fabrication, and scaffold design.
• To discuss cellular responses and future directions in therapeutic cornea development.

Main Methods:

• Review of current research and clinical applications in cornea tissue engineering.
• Analysis of biomaterials, fabrication techniques, and scaffold structures.
• Evaluation of cellular responses to engineered cornea scaffolds.

Main Results:

• Tissue engineering provides a promising alternative to donated cornea tissue.
• Careful selection of biomaterials and fabrication methods improves healing outcomes.
• Engineered cornea tissues offer reduced risks of immune rejection and storage issues.

Conclusions:

• Cornea tissue engineering is advancing rapidly, offering a sustainable solution to tissue scarcity.
• Optimized biomaterials and fabrication methods are key to successful therapeutic tissue development.
• Future research will focus on refining techniques for enhanced clinical application and patient recovery.